Table 1.
Patient characteristics.
| Characteristic | Number |
|---|---|
| Total patients with NET | 56 |
| Total patients treated with CAPTEM | 12 |
| Median age | 62 years |
| Male : female ratio | 1 : 1 |
| Mean duration of treatment before progression | 10.8 months |
| CAPTEM used as front-line systemic therapy | 9 patients |
| Median chromogranin A | 221 |
| Concomitant Somatostatin analogues use | 5 patients |
| Grade I | 1 |
| Grade II | 7 |
| Grade III | 4 |